IDO1 and neoplasm: Despite its anti-tumor effects, IFNγ can also induce the expression of PD-L1 and indoleamine 2,3-dioxygenase (IDO) and can therefore contribute to the tumor’s escape from immune surveillance and allow tumor progression [38].